Evaluation of Wire Electrodes to Activate the Expiratory Muscles to Restore Cough
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Respiratory infections, such as pneumonia and bronchitis, occur frequently in the spinal cord injured population, due to paralysis of the muscles responsible for coughing. Using spinal cord stimulation techniques, these muscles can be activated to restore an effective cough mechanism.
| Condition | Intervention |
|---|---|
|
Spinal Cord Injuries Spinal Cord Diseases Paralysis Central Nervous System Diseases Cough |
Procedure: Spinal Cord Stimulation Device: Expiratory Muscle Stimulator |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Evaluation of Wire Electrodes to Activate the Expiratory Muscles to Restore Cough |
- Measurements of airway pressure, expired volume and expiratory flow rate to evaluate efficacy of cough. [ Time Frame: one year ] [ Designated as safety issue: No ]
- Assessment of need for caregiver support for secretion removal. [ Time Frame: one year ] [ Designated as safety issue: No ]
- Assessment of ease in expectoration of secretions. [ Time Frame: one year ] [ Designated as safety issue: No ]
- Incidence of respiratory tract infections. [ Time Frame: one year ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 6 |
| Study Start Date: | October 2009 |
| Estimated Study Completion Date: | March 2013 |
| Estimated Primary Completion Date: | September 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Spinal Cord Stimulation
The participant will have wire electrodes temporarily placed - by a routine surgical procedure - over the surface of the spinal cord on the lower back. These electrodes will be activated in the operating room and the degree of muscle activation assessed. The wire electrodes will then be removed. Small, disc electrodes will then be permanently implanted to stimulate expiratory muscles and restore cough. These electrodes are activated using an external control unit.
|
Procedure: Spinal Cord Stimulation
The participant will have wire electrodes temporarily placed - by a routine surgical procedure - over the surface of the spinal cord on the lower back. These electrodes will be activated in the operating room and the degree of muscle activation assessed. The wire electrodes will then be removed. Small, disc electrodes will then be permanently implanted to stimulate expiratory muscles and restore cough. These electrodes are activated using an external control unit.
Other Name: NeuroControl Expiratory Muscle Stimulation (IDE G980267)
Device: Expiratory Muscle Stimulator
The expiratory muscle stimulator consists of three small electrodes (metal discs) implanted over the surface of their spinal cords on the lower back to stimulate the expiratory muscles and restore cough. These electrodes are connected to an implanted receiver in the abdomen or chest wall. The device is activated through an external antenna connected to an external control box.
|
Detailed Description:
Patients with cervical and thoracic spinal cord injuries often have paralysis of a major portion of their expiratory muscles — the muscles responsible for coughing — and therefore, lack a normal cough mechanism. Consequently, most of these patients suffer from a markedly reduced ability to clear airway secretions, a factor which contributes to the development of recurrent respiratory tract infections such as pneumonia and bronchitis. In fact, pneumonia is a major cause of death in this patient population.
In a recent clinical trial, we have shown that the expiratory muscles can be electrically activated by spinal cord stimulation (SCS), a technique which involves the surgical placement of disc electrodes on the surface of the spinal cord. This method is successful in achieving an effective means of expiratory muscle activation, as demonstrated by the generation of large airway pressures and peak airflow rates. Importantly, SCS facilitates secretion removal, reduces the need for caregiver support, reduces the incidence of respiratory tract infections and improves life quality. This method therefore has the potential to reduce health care costs and improve survival in spinal cord injured subjects.
The purpose of this trial is to directly compare activation of the expiratory muscles using wire electrodes, which can be inserted percutaneously through a needle, with the previously employed disc electrodes.
In this trial, researchers will study 6 adults (18-70 years old) with spinal injuries (T5 level or higher), at least 12 months following the date of injury. After an evaluation including medical history, a brief physical examination, and initial testing, each participant will undergo a surgical procedure to implant small electrodes (metal discs) over the surface of the spinal cord on the lower back to stimulate the expiratory muscles and restore cough. Prior to permanent implantation of this system, wire and disc electrodes will be compared by assessing the degree of expiratory muscle activation with each electrode type. The disc electrodes will then be permanently implanted, allowing the participant to have use of a fully functioning stimulation system to restore an effective cough.
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Stable spinal cord injury T5 level or higher
- Expiratory muscle weakness
Exclusion Criteria:
- Significant cardiovascular disease
- Active lung disease
- Brain disease
- Scoliosis, chest wall deformity, or marked obesity
Contacts and Locations| United States, Ohio | |
| MetroHealth Medical Center | |
| Cleveland, Ohio, United States, 44109 | |
| Principal Investigator: | Anthony F. DiMarco, MD | Case Western Reserve University |
More Information
Publications:
| Responsible Party: | Anthony F. DiMarco, Professor of Medicine, Case Western Reserve University |
| ClinicalTrials.gov Identifier: | NCT00995215 History of Changes |
| Other Study ID Numbers: | RC1 NS068576, IRB08-00269, IRB98-00091, RC1NS068576 |
| Study First Received: | October 14, 2009 |
| Last Updated: | May 23, 2012 |
| Health Authority: | United States: Food and Drug Administration |
Keywords provided by Case Western Reserve University:
|
spinal cord injury SCI paralysis |
cough cervical spinal cord injury thoracic spinal cord injury |
Additional relevant MeSH terms:
|
Central Nervous System Diseases Cough Nervous System Diseases Spinal Cord Diseases Spinal Cord Injuries Paralysis Respiration Disorders |
Respiratory Tract Diseases Signs and Symptoms, Respiratory Signs and Symptoms Trauma, Nervous System Wounds and Injuries Neurologic Manifestations |
ClinicalTrials.gov processed this record on May 16, 2013